The implant is designed for use in breast reconstruction, augmentation or revision surgeries and was created using a new gel to achieve medium firmness.
The approval marks the third firmness option for Allergan’s breast implant portfolio.
More articles on supply chain:
Why driverless cars could magnify the organ donor shortage
Amazon’s newest endeavor: A floating warehouse
How ‘phantom inventory’ could be hurting your supply chain
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.